MeSH term
Frequency | Condition_Probility | Amino Acid Substitution | 2 | 0.0 |
Animals | 24 | 0.0 |
COS Cells | 2 | 0.0 |
*Cell Cycle Proteins | 14 | 1.0 |
Cell Line | 12 | 0.0 |
Chromosome Breakage | 3 | 3.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Hela Cells | 7 | 0.0 |
Humans | 54 | 0.0 |
Macromolecular Substances | 4 | 0.0 |
Protein Binding | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 40 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Cell Line, Transformed | 7 | 0.0 |
Mitomycin/pharmacology | 12 | 13.0 |
Radiation, Ionizing | 4 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 27 | 0.0 |
Chromosome Aberrations | 2 | 0.0 |
DNA Damage/*genetics | 2 | 3.0 |
Fanconi Anemia/*genetics | 10 | 21.0 |
Genes, Recessive | 3 | 0.0 |
Nuclear Proteins/*genetics | 6 | 1.0 |
Apoptosis | 3 | 0.0 |
DNA Damage | 6 | 0.0 |
DNA Repair | 10 | 1.0 |
*DNA-Binding Proteins | 8 | 0.0 |
Models, Biological | 8 | 0.0 |
Mutation | 7 | 0.0 |
*Nuclear Proteins | 5 | 0.0 |
Oxidative Stress | 2 | 0.0 |
Oxygen/metabolism | 2 | 0.0 |
Proteins/genetics | 4 | 0.0 |
BRCA1 Protein/metabolism | 2 | 5.0 |
Female | 13 | 0.0 |
Male | 13 | 0.0 |
Nuclear Proteins/metabolism | 4 | 0.0 |
Alleles | 3 | 0.0 |
Cell Division | 3 | 0.0 |
Cells, Cultured | 4 | 0.0 |
DNA/metabolism | 2 | 0.0 |
*DNA Damage | 7 | 1.0 |
DNA-Binding Proteins/*physiology | 3 | 0.0 |
Flow Cytometry | 3 | 0.0 |
G2 Phase | 2 | 1.0 |
Mice | 9 | 0.0 |
Mitosis | 2 | 0.0 |
Nuclear Proteins/*physiology | 2 | 1.0 |
Phosphorylation | 3 | 0.0 |
Time Factors | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
Epoxy Compounds/pharmacology | 4 | 44.0 |
Fanconi Anemia/genetics | 3 | 25.0 |
Genetic Complementation Test | 12 | 2.0 |
Hamsters | 2 | 0.0 |
Ubiquitin/*metabolism | 4 | 2.0 |
Ultraviolet Rays | 4 | 0.0 |
Comparative Study | 5 | 0.0 |
DNA Primers | 2 | 0.0 |
DNA-Binding Proteins/genetics/physiology | 2 | 2.0 |
Genetic Vectors/genetics | 3 | 1.0 |
Proteins/genetics/physiology | 2 | 3.0 |
RNA-Binding Proteins/genetics/physiology | 2 | 40.0 |
Signal Transduction/physiology | 2 | 0.0 |
BRCA2 Protein/genetics/metabolism | 2 | 40.0 |
DNA Damage/genetics | 2 | 4.0 |
DNA Repair/*genetics | 4 | 1.0 |
Genetic Heterogeneity | 3 | 1.0 |
Genotype | 5 | 0.0 |
Adolescent | 2 | 0.0 |
Child | 3 | 0.0 |
Child, Preschool | 3 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Chromosomes, Human/drug effects | 2 | 40.0 |
Cross-Linking Reagents/pharmacology | 6 | 4.0 |
DNA Mutational Analysis | 5 | 0.0 |
DNA Repair/genetics | 2 | 1.0 |
Forecasting | 2 | 0.0 |
Mice, Knockout | 4 | 0.0 |
Phenotype | 6 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Signal Transduction | 2 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Base Sequence | 4 | 0.0 |
*DNA Repair | 5 | 0.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Nuclear Proteins/*metabolism | 6 | 0.0 |
Recombination, Genetic | 3 | 0.0 |
BRCA1 Protein/*metabolism | 5 | 6.0 |
Fanconi Anemia/*genetics/metabolism | 4 | 50.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Proteins/*metabolism | 2 | 0.0 |
Blotting, Western | 4 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Pedigree | 3 | 0.0 |
Chromatin/metabolism | 2 | 0.0 |
Fanconi Anemia/*metabolism | 5 | 41.0 |
Nuclear Proteins/physiology | 2 | 2.0 |
Ubiquitin/metabolism | 5 | 2.0 |
Cisplatin/pharmacology | 2 | 1.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Gene Deletion | 3 | 0.0 |
Homozygote | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
BRCA2 Protein/genetics/*metabolism | 2 | 40.0 |
Cell Line, Tumor | 3 | 0.0 |
Transfection | 8 | 0.0 |
Gene Therapy/*methods | 2 | 0.0 |
Immunoprecipitation | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Oxidation-Reduction | 2 | 0.0 |
*Oxidative Stress | 2 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Cell Nucleus/metabolism | 4 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 2 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
BRCA2 Protein/*metabolism | 2 | 20.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Zebrafish | 2 | 1.0 |
Exons | 2 | 0.0 |
Introns | 2 | 0.0 |
Nuclear Proteins/genetics | 2 | 0.0 |
Kinetics | 2 | 0.0 |
Cell Fusion | 2 | 0.0 |
Genes, BRCA1 | 4 | 2.0 |
Adult | 2 | 0.0 |
Fanconi Anemia/*genetics/metabolism/pathology | 2 | 66.0 |
DNA Repair/*physiology | 2 | 1.0 |
Linkage (Genetics) | 2 | 0.0 |
*Mutation | 4 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
DNA Methylation | 2 | 0.0 |
*Genes, BRCA2 | 3 | 1.0 |
Jews/*genetics | 2 | 1.0 |
Disease Models, Animal | 2 | 0.0 |
